Severe spruelike enteropathy due to olmesartan.
Villous atrophy and negative serologic testing is a diagnostic challenge, and the rarer possibility of drug-induced enteritis should be considered. We report a rare case of severe spruelike enteritis due to olmesartan that completely resolved after withdrawal of the drug. The possibility that patient labeled as "refractory" celiac disease may actually be due to drug treatment should always be taken into consideration, to avoid unnecessary investigations.
Gioia
G
Fiorucci
Efisio
E
Puxeddu
Renato
R
Colella
Gian
G
Paolo Reboldi
Vincenzo
V
Villanacci
Gabrio
G
Bassotti
D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D002446:Celiac Disease / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use
D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan